Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results

Presenter: Stephen G. Ellis

REGISTER for free or LOG IN to view this content

Become a GOLD or PLATINUM member to access PowerPoint files, presentation audio, and video

Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease:  ABSORB III Trial 2-Year Results

We Recommend